Pillar Pharmaceuticals II, L.P., Director, 10% Owner at IDERA PHARMACEUTICALS, INC. (IDRA), sold 901,630 shares at $2.26 ($2.0M) on 2017-05-01, disclosed to the SEC on 2017-05-03.
Open-market sale of $2.0M IDRA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 41,578 | $94K | 4.6% |
| 2 | $2.26 | 41,578 | $94K | 4.6% |
| 3 | $2.26 | 409,237 | $925K | 45.4% |
| 4 | $2.26 | 409,237 | $925K | 45.4% |
| Total | $2.26 avg | 901,630 | $2.0M | 100% |
| Filing → |
| IDRA | SELL | 2017-12-15 | $4.9M | — | Filing → |